Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2005-03-01 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GIVET ([ND]), None
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA MARINE : revenue, balance sheet and financial ratios
PHARMACIE DE LA MARINE is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GIVET ([ND]),
this company of category PME
shows in 2022 a revenue of 3.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA MARINE (SIREN 481120681)
Indicator
2024
2023
2022
2021
2020
2019
2019
2018
2017
Revenue
N/C
N/C
3 041 482 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
120 734 €
93 383 €
189 688 €
179 036 €
39 627 €
240 729 €
141 721 €
192 167 €
179 704 €
EBITDA
N/C
N/C
270 782 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.2%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE LA MARINE generates positive net income of 121 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 180 k€ -> 121 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
120 734 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 189%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
188.537%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
30.526%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA MARINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2019
2020
2021
2022
2023
2024
Debt ratio
8.467
6.449
5.642
1298.967
1031.119
515.499
316.261
245.603
188.537
Financial autonomy
82.46
84.795
85.571
6.355
7.693
14.451
21.574
25.83
30.526
Repayment capacity
None
None
None
None
None
None
8.889
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
6.8%
None%
None%
Sector positioning
Debt ratio
188.542024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average
In 2024, the debt ratio of PHARMACIE DE LA MARINE (188.54) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
30.53%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average
In 2024, the financial autonomy of PHARMACIE DE LA MARINE (30.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
8.89 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DE LA MARINE (8.89) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 170.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
170.694
Liquidity indicators evolution PHARMACIE DE LA MARINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2019
2020
2021
2022
2023
2024
Liquidity ratio
195.18
258.995
261.261
260.601
170.849
194.628
191.515
184.821
170.694
Interest coverage
None
None
None
None
None
None
2.598
None
None
Sector positioning
Liquidity ratio
170.692024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Average
In 2024, the liquidity ratio of PHARMACIE DE LA MARINE (170.69) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
2.6x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Good
In 2022, the interest coverage of PHARMACIE DE LA MARINE (2.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA MARINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
269 962 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
34
0
0
Customer payment term (days)
0
0
0
0
0
0
4
0
0
Supplier payment term (days)
0
0
0
0
0
0
32
0
0
Positioning of PHARMACIE DE LA MARINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA MARINE is estimated at
1 685 535 €
(range 1 173 780€ - 2 521 658€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1173k€1685k€2521k€
1 685 535 €Range: 1 173 780€ - 2 521 658€
NAF 5 année 2024
Valuation method used
Net Income Multiple
120 734 €
×
14.0x
=1 685 536 €
Range: 1 173 781€ - 2 521 658€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA MARINE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA MARINE
What is the revenue of PHARMACIE DE LA MARINE ?
The revenue of PHARMACIE DE LA MARINE in 2022 is 3.0 M€.
Is PHARMACIE DE LA MARINE profitable?
Yes, PHARMACIE DE LA MARINE generated a net profit of 121 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA MARINE ?
The headquarters of PHARMACIE DE LA MARINE is located in GIVET ([ND]).
Where to find the tax return of PHARMACIE DE LA MARINE ?
The tax return of PHARMACIE DE LA MARINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA MARINE operate?
PHARMACIE DE LA MARINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart